Boothbay Fund Management, LLC Dia Medica Therapeutics Inc. Transaction History

Boothbay Fund Management, LLC

  • $3.37 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.86 - $2.62 $38,321 - $53,979
-20,603 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$3.43 - $4.65 $35,332 - $47,899
-10,301 Reduced 33.33%
20,603 $77,000
Q3 2021

Nov 15, 2021
SELL
$3.1 - $4.32 $48,539 - $67,642
-15,658 Reduced 33.63%
30,904 $124,000
Q3 2020

Nov 16, 2020
BUY
$3.91 - $7.15 $182,057 - $332,918
46,562 New
46,562 $197,000

Others Institutions Holding DMAC

# of Institutions
36
Shares Held
3.87M
Call Options Held
1.3K
Put Options Held
1K
View Full List

About DiaMedica Therapeutics Inc.

DMAC Quotes by TradingView
  • Ticker DMAC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,443,100
  • Market Cap $116M
  • Description
  • DiaMedica Therapeutics Inc., a clinical stage biopharmaceutical company, develops treatments for neurological and kidney diseases. The company's lead drug candidate is DM199, a recombinant human tissue kallikrein-1 protein, which is in Phase 2 REDUX trial for the treatment of patients with moderate or severe chronic kidney disease caused by Type...
More about DMAC
Track This Portfolio

Track Boothbay Fund Management, LLC Portfolio

Follow Boothbay Fund Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Boothbay Fund Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Boothbay Fund Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email